Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel DiseaseMarieke J. H. Coenen, H. Akol, Sita H. Vermeulen et al.|Gastroenterology|2015Cited by 199
Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemiaM. W. Hess, Joost P.H. Drenth, Jeroen H. F. de Baaij et al.|Pharmacogenetics and Genomics|2016Cited by 33